HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

UH researchers work towards a mobile intervention for Black American smokers with HIV

HIV remains a critical global public health issue and a significant threat to global health security after having claimed more than 40 million lives, according to the World Health Organization.

4 Jan 2023

Analysis finds more than 100 new genetic risk factors strongly linked to colorectal cancer

A comprehensive analysis of more than 100,000 colorectal cancer (CRC) cases, led by researchers at the Fred Hutchinson Cancer Center in Seattle and 200 scientific collaborators worldwide, has identified more than 100 new genetic risk factors strongly linked with the disease.

20 Dec 2022

HIV outbreak persists as officials push back against containment efforts

Brooke Parker has spent the past two years combing riverside homeless encampments, abandoned houses, and less traveled roads to help contain a lingering HIV outbreak that has disproportionately affected those who live on society's margins.

19 Dec 2022

Enveloped viruses show greater cross-species transmission, according to new research

New research found that enveloped viruses harbor greater cross-species transmissibility and are more likely to cause zoonotic infections than nonenveloped viruses.

9 Dec 2022

Multi-stage HIV vaccine regimen shows promising results in Phase 1 clinical trial

The George Washington University Vaccine Research Unit in partnership with Scripps Research, IAVI, Fred Hutchinson Cancer Center (FHCC) and the National Institutes of Health, National Institute of Allergy and Infectious Diseases Vaccine Research Center published the results of their Phase 1 Clinical Trial in Science.

8 Dec 2022

Self-service vending machine filled with harm reduction supplies helps prevent overdoses

More than 107,000 Americans died from drug overdose in 2021, highlighting the need for evidence-based interventions.

6 Dec 2022

First-in-humans test provides promising results for a broadly neutralizing antibody HIV vaccine

A Phase 1 clinical trial provides promising results for a broadly neutralizing antibody (bnAb) HIV vaccine, according to a new study.

1 Dec 2022

The Elton John AIDS Foundation: a powerful force in the end to the AIDS epidemic

To commemorate World AIDS Day, News Medical spoke to Anne Aslett, Chief Executive Officer of the Elton John AIDS Foundation, about the work of the foundation and the actions required to address inequalities and help end AIDS.

1 Dec 2022

Miracles Start in the Lab: the quest to find a vaccine to cure AIDS

To commemorate World AIDS Day, News Medical spoke to Dr. Larry Corey, an internationally renowned expert in virology, immunology, and vaccine development, and the former president and director of Fred Hutch, about his work within the field of HIV/AIDS research and vaccine development.

30 Nov 2022

Certain TB correlates of protection linked with the likelihood of becoming infected with Mycobacterium tuberculosis

Researchers from the University of Oxford have today reported findings from a study that investigated whether previously identified correlates of protection associated with risk of full-blown tuberculosis (TB) disease could also be associated with risk of infection from the bacteria that causes TB.

15 Nov 2022

New $3.5 million NCI grant to help improve care for cervical cancer patients in Botswana

For more than two decades, experts at Penn Medicine have worked hand in hand with local partners to improve health care and outcomes in the sub-Saharan African nation of Botswana.

11 Nov 2022

Researchers highlight a significant cancer disparity among young Black men in the American South

Research shows that incidences of Kaposi's sarcoma among people living with HIV have fallen significantly over the past two decades, but a new evaluation of data led by researchers at UTHealth Houston highlights a significant disparity among one particular demographic – young Black men in the American South.

10 Nov 2022

Findings from a multi-year initiative aimed at improving HIV health outcomes

The results of a multi-year initiative aimed at improving HIV health outcomes for Black men who have sex with men (MSM) are published in a new Supplement in the peer-reviewed journal AIDS Patient Care and STDs.

7 Nov 2022

Health Heroines: Supporting Women and Striving for Universal Health Coverage

In this interview we speak to Ms. Anita Kouvahey-Eklu, a recent Heroines of Health award winner, about her work in addressing gender inequalities within healthcare.

From Women in Global Health 7 Nov 2022

New initiative to improve HIV health outcomes for Black men who have sex with men

27 Oct 2022

$3 million grant to support the expansion of Midwest AIDS Training and Education Center at UIC

The Midwest AIDS Training and Education Center at the University of Illinois Chicago will expand its services nationwide with the help of a new $3 million grant.

26 Oct 2022

Three-dose regimen of HEPLISAV-B vaccine fully protects people living with HIV, data shows

The AIDS Clinical Trials Group (ACTG), the world's largest HIV research network whose focus has expanded to include evaluating outpatient treatment for COVID-19, today presented a session demonstrating that a three-dose regimen of the HEPLISAV-B vaccine fully protected people living with HIV at IDWeek 2022, taking place in Washington D.C. from October 19-22, 2022.

20 Oct 2022

Medically tailored meals could result in net cost savings of $13.6 billion each year

Adopting more programs that make and deliver medically tailored meals to people with serious, diet-sensitive diseases could result not only in improved health outcomes in the form of fewer hospitalizations nationally, but in a net cost savings of approximately $13.6 billion each year, according to new research from the Friedman School of Nutrition Science and Policy at Tufts University.

17 Oct 2022

COVID-19 vaccines show favorable immunogenicity and efficacy in people living with HIV

In a recent study published in the International Journal of Infectious Diseases, researchers assessed the efficacy of coronavirus disease 2019 (COVID-19) vaccines in people living with human immunodeficiency virus (HIV).

16 Oct 2022

Duke receives federal funding for HIV vaccine research

The Duke Human Vaccine Institute and the Department of Surgery at Duke University School of Medicine received a grant from the National Institute of Allergy and Infectious Diseases for HIV vaccine research that could total $25.9 million with full funding over five years.

11 Oct 2022